Free Trial

Ensysce Biosciences (ENSC) Institutional Ownership

Ensysce Biosciences logo
$0.34 -0.04 (-10.47%)
As of 11:08 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Ensysce Biosciences (NASDAQ:ENSC)

Current
Institutional Ownership
Percentage
5.63%
Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$610.65K
Number of
Institutional Sellers
(last 12 months)
0
Get ENSC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ensysce Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ENSC Institutional Buying and Selling by Quarter

Ensysce Biosciences Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2026Adage Capital Partners GP L.L.C.149,711$138K0.0%+100.4%4.122%
2/12/2026DRW Securities LLC98,481$91K0.0%+42.4%2.713%
11/17/2025Citadel Advisors LLC14,518$34K0.0%N/A0.489%
11/14/2025Virtu Financial LLC14,222$34K0.0%N/A0.479%
10/22/2025 TRU Independence Asset Management 2 LLC10,500$25K0.0%N/A0.354%
5/16/2025Murchinson Ltd.140,000$358K0.0%N/A5.905%
5/16/2025Adage Capital Partners GP L.L.C.74,711$191K0.0%+49.4%3.151%
2/14/2025Adage Capital Partners GP L.L.C.50,000$407K0.0%N/A3.817%
11/15/2024Anson Funds Management LP983,518$236K0.0%N/A11.151%
11/15/2023Sabby Management LLC96,973$134K0.1%-69.9%3.079%
8/14/2023Anson Funds Management LP36,261$65K0.0%N/A2.833%
5/1/2023Virtu Financial LLC13,433$65K0.0%N/A1.049%


ENSC Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Ensysce Biosciences shares: Murchinson Ltd. ($358K), Anson Funds Management LP ($236K), Adage Capital Partners GP L.L.C. ($138K), DRW Securities LLC ($91K), Citadel Advisors LLC ($34K), and Virtu Financial LLC ($34K), and TRU Independence Asset Management 2 LLC ($25K).Learn more on Ensysce Biosciences' institutional investors.

5.63% of Ensysce Biosciences' stock is owned by institutional investors. Learn more on ENSC's institutional investor holdings.

The following institutional investors have purchased Ensysce Biosciences' stock in the last 24 months: Anson Funds Management LP ($983.52K), Adage Capital Partners GP L.L.C. ($149.71K), Murchinson Ltd. ($140K), DRW Securities LLC ($29.34K), Citadel Advisors LLC ($14.52K), Virtu Financial LLC ($14.22K), and TRU Independence Asset Management 2 LLC ($10.50K).

Institutional investors have bought a total of 308,287 shares in the last 24 months. This purchase volume represents approximately $610.65K in transactions.



This page (NASDAQ:ENSC) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners